Dasatinib Carboxylic Acid,
910297-53-9,
UNII-83FL89EU88,
83FL89EU88,
4-[6-[[5-[[(2-CHLORO-6-METHYLPHENYL)AMINO]CARBONYL]-THIAZOL-2-YL]AMINO]-2-METHYL-PYRIMIDIN-4-YL]-1-PIPERAZINEACETIC ACID,
Dasatinib metabolite M6,
SCHEMBL1704971,
CTK5G8814,
DTXSID10474430,
VMCDXJFWSYUNPO-UHFFFAOYSA-N,
ZINC22055422,
AKOS030255279,
BMS-573188,
AC-30419,
RT-012229,
FT-0665479,
A1-03824,
1-Piperazineacetic acid, 4-(6-((5-(((2-chloro-6-methylphenyl)amino)carbonyl)-2-thiazolyl)amino)-2-methyl-4-pyrimidinyl)-,
2-(4-(6-((5-((2-Chloro-6-methyl-phenyl)carbamoyl)thiazol-2-yl)amino)-2-methyl-pyrimidin-4-yl)piperazin-1-yl)acetic acid,
2-(4-(6-(5-((2-Chloro-6-methylphenyl)carbamoyl)thiazol-2-ylamino)-2-methylpyrimidin-4-yl)piperazin-1-yl)acetic acid,
2-(4-(6-(5-(2-chloro-6-methylphenylcarbamoyl)thiazol-2-ylamino)-2-methylpyrimidin-4-yl)piperazin-1-yl)acetic acid,
4-[6-[[5-[[(2-Chloro-6-methylphenyl)amino]carbonyl]-2-thiazolyl]amino]-2-methyl-4-pyrimidinyl]-1-piperazineacetic Acid,
CID11854012,
CID 11854012,
4-[6-[[5-[[ amino]carbonyl]-2-thiazolyl]amino]-2-methyl-4-pyrimidinyl]-1-piperazineaceticAcid,